Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571. (Q34134516)

31 July 2017

title

Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571. (English)

1 reference

31 July 2017

Brian J Druker

0 references

Amie S Corbin

1 reference

31 July 2017

Elisabeth Buchdunger

series ordinal

1 reference

31 July 2017

Furet Pascal

series ordinal

1 reference

31 July 2017

language of work or name

English

0 references

publication date

20 June 2002

1 reference

Journal of Biological Chemistry

31 July 2017

published in

1 reference

31 July 2017

volume

277

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

32214-32219

1 reference

Chronic myelogenous leukemia: biology and therapy

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Roots of clinical resistance to STI-571 cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

21 January 2018

Identifiers

DOI

10.1074/JBC.M111525200

1 reference

release_kcixtp2775clrjv6gk5u5zvanq

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kcixtp2775clrjv6gk5u5zvanq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference